Skip to main content

10 Result(s)

within E. González-Barca Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Umbilical cord blood transplantation from unrelated donors in an adult weighing 90 kilograms. Role of immunosuppression in engraftment

    A 40-year-old male weighing 90 kilograms was diagnosed with acute myeloblastic leukaemia M5a which was resistant to chemotherapy. Neither a related nor an unrelated HLA-compatible bone marrow donor could be fo...

    E González-Barca, S Querol, A Grañena, J Sarra, G Sirchia… in Bone Marrow Transplantation (1997)

  2. No Access

    Article

    Noninvasive mechanical ventilation in a patient with respiratory failure after hematopoietic progenitor transplantation

    Respiratory failure requiring orotracheal intubation (OTI) and mechanical ventilation (MV) is almost always a fatal complication in patients who undergo hematopoietic progenitor transplantation (HPT). We prese...

    D Marín, E González-Barca, E Domingo, J Berlanga, A Grañena in Bone Marrow Transplantation (1998)

  3. No Access

    Article

    Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)

    Twenty-nine B cell follicular lymphoma (FL) patients had their BM (n = 12) or PBPC (n = 17) purged using a panel of monoclonal antibodies and immunomagnetic beads (IMB). The median recovery of nucleated cells (NC...

    GA Martín-Henao, M Picón, A Limón, M Carmona, B Amill… in Bone Marrow Transplantation (1999)

  4. No Access

    Article

    Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival

    The role of autologous stem cell transplant (ASCT) in indolent lymphomas is a controversial issue. From 1994 to 1999, we performed ASCT with immunologically purged progenitor cells in 15 patients with advanced...

    E González-Barca, A Fernández de Sevilla, A Domingo-Claros… in Bone Marrow Transplantation (2000)

  5. No Access

    Article

    Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes

    The arbitrary threshold of 5 × 109/L chronic lymphocytic leukemia (CLL)-like lymphocytes differentiates monoclonal B lymphocytosis (MBL) from CLL. There are no prospective studies that search for the optimal cut-...

    A. C. Oliveira, A. Fernández de Sevilla, A. Domingo, E. De La Banda… in Annals of Hematology (2015)

  6. Article

    Open Access

    Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

    The dissemination in the central nervous system (CNS) is an uncommon but fatal complication occurring in patients with diffuse large B-cell lymphoma (DLBCL). Standard prophylaxis has been demonstrated to reduc...

    E. González-Barca, M. Canales, A. Salar, J. J. Ferreiro-Martínez… in Annals of Hematology (2016)

    Download PDF (382 KB) View Article

  7. No Access

    Article

    Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

    Guidelines recommend autologous stem cell transplantation (ASCT) consolidation in first complete or partial response after regimens including rituximab (R) and high-dose AraC (HDAC), but its use beyond that re...

    A. García-Noblejas, J. Cannata-Ortiz, E. Conde, E. González Barca… in Annals of Hematology (2017)

  8. No Access

    Article

    Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series

    Burkitt’s monomorphic posttransplant lymphoproliferative disorder (B-PTLD) is an uncommon subtype of PTLD. Owing to the paucity of this complication, clinical characteristics and outcome has not been fully des...

    S. Bobillo, P. Abrisqueta, B. Sánchez-González, E. Giné, S. Romero… in Annals of Hematology (2018)

  9. No Access

    Article

    Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

    Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) who relapse/progress after first line chemoimmunotherapy. Long-ter...

    E. González-Barca, A. Boumendil, D. Blaise, M. Trněný… in Bone Marrow Transplantation (2020)

  10. No Access

    Article

    A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection

    Traceability of patients who are candidates for Hematopoietic cell transplant (HCT) is crucial to ensure HCT program quality. Continuous knowledge of both a detailed registry from a HCT program and final exclu...

    R. Parody, I. Sánchez-Ortega, A. Mussetti, B. Patiño… in Bone Marrow Transplantation (2022)